Report Highlights
The global self-testing kits market should reach $35.9 billion by 2022 and more than $64.5 billion by 2027, with a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2022-2027.
Report Includes
- 15 data tables and 32 additional tables
- A comprehensive overview and up-to-date analysis of the global markets for self-testing kits
- Analyses of the global market trends, with historic market revenue for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the upcoming market potential for medical self-testing kits, industry growth drivers, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size and revenue forecast for self-testing kits in USD million values, and corresponding market share analysis based on test kit type, distribution channel, and region
- Regional market outlook and country-specific data and analysis for medical self-testing kits with products sub-segmented into blood glucose testing, pregnancy & fertility testing, cholesterol testing, urine analysis, COVID-19 testing, HIV rapid diagnostic tests, etc.
- Latest information on the key market drivers and opportunities, industry shifts and regulations, and other demographic factors that will influence this market demand in the coming years (2022-2027)
- Coverage of the technological, economic, and business considerations of the prevailing self-testing kits market, and its vendor landscape
- Insight into the major technology updates, government regulations, breakthrough innovations, collaborations and developments, and costs and benefits of self-testing kits in the medical devices industry
- Porter’s five forces analysis for the self-testing kits market considering the dominant micro-and macro-environmental factors
- Identification of the major stakeholders and analysis of their competitive landscape based on recent developments and segmental revenues
- Company profiles of major players within the industry, including Abbott; Becton, Dickinson, and Co. (BD); F. Hoffmann-La Roche Ltd. and Quidel Corp.
Report Scope
The current report will provide an in-depth look at the self-testing kits market. This report analyzes the market trends of self-testing kits with data from 2021, estimates from 2022, and projections of compound annual growth rates (CAGRs) through 2027 (forecast period 2022–2027) and examines regional markets for self-testing kits. This report will highlight the current and future market potential of self-testing kits and provide a detailed analysis of the competitive environment. Regulatory scenarios, drivers, restraints and opportunities will be covered in the report. The report also includes market projections for 2027 and estimates market share for key market players.
In this report, the market has been segmented based on test type, distribution channel and geographic region. Test types include blood glucose testing, pregnancy and fertility testing, COVID-19 testing, HIV rapid diagnostic tests, and others. Distribution channels include retail and e-commerce.
The regions covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). Individual countries covered include the U.S., Germany, the U.K., Italy, France, Japan, China and India.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||
| Base year market size | $22.1 billion | ||||||||||||||||||
| Market size forecast | $64.5 billion | ||||||||||||||||||
| Growth rate | CAGR of 12.4% from 2022 to 2027 | ||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||
| Segments covered | Test Type, Distribution Channel | ||||||||||||||||||
| Regions covered | North America, Europe, Asia Pacific, and Rest of the World (RoW) | ||||||||||||||||||
| Countries covered | U.S., Canada, Germany, France, U.K., Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Rest of Asia-Pacific | ||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||
| Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets (HLC176E)
- Carbon Credits Market: Global Outlook (EGY200A)
- Drugs and Diagnostics for Hematological Disorders: Global Markets (PHM116C)
- Global Flame and Smoke Detectors Markets (MFG092A)
- Biodegradable Polymers: Global Markets and Technologies (PLS025K)
Related Reports
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
In Vitro Diagnostics (IVD) Analyzers: Global Market
The global market for In Vitro Diagnostics (IVD) analyzers is estimated to increase from $12.9 billion in 2023 to reach $16.3 billion by 2028, at a compound annual growth rate (CAGR) of 4.7% from 2023 through 2028.
Molecular Diagnostics: Technologies and Global Markets
The global molecular diagnostics market should reach $42.6 billion by 2026 from $17.6 billion in 2021 at a compound annual growth rate (CAGR) of 19.3% for the forecast period of 2021 to 2026.
Recent Reports
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Global Orthodontic and Orthopedic Market
The global market for orthodontic devices is expected to grow from $18.9 billion in 2023 and projected to reach $29.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023 to 2028.Report Includes
Global Medical Dynamometer Market
The global market for medical dynamometers is estimated to increase from $547.5 million in 2023 to reach $780.1 million by 2028, at a compound annual growth rate (CAGR) of 7.3% from 2023 through 2028.
Global Insulin Pen Market
This report examines the global insulin pen market. It includes a detailed analysis and prediction of commercially significant products such as reusable and disposable insulin pens. This report investigates global insulin pen market patterns and features between 2022–2028, offering valuable insights and forecasts.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More